Alliancebernstein L.P. Humacyte, Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Humacyte, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 145,560 shares of HUMA stock, worth $224,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145,560
Previous 65,590
121.92%
Holding current value
$224,162
Previous $112,000
171.43%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HUMA
# of Institutions
168Shares Held
54.2MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$10.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$6.76 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$5.28 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$4.54 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $159M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...